propranolol has been researched along with Choroid Neovascularization in 4 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Determine the safe dose of intravitreal propranolol (IVP), and evaluate its inhibitory effect on laser-induced choroidal neovascularization (CNV)." | 1.42 | Ocular Safety of Intravitreal Propranolol and Its Efficacy in Attenuation of Choroidal Neovascularization. ( Ahmadieh, H; Aldavood, SJ; Daftarian, N; Darjatmoko, SR; Gurel, Z; Kaharkaboudi, A; Lavine, JA; Nourinia, R; Rezaei Kanavi, M; Safi, S; Sheibani, N; Taghavi, SI; Wang, S, 2015) |
| "Propranolol-treated mice demonstrated a 50% reduction in laser-induced CNV." | 1.39 | Attenuation of choroidal neovascularization by β(2)-adrenoreceptor antagonism. ( Ip, MS; Lavine, JA; Sang, Y; Sheibani, N; Wang, S, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Omri, S | 1 |
| Tahiri, H | 1 |
| Pierre, WC | 1 |
| Desjarlais, M | 1 |
| Lahaie, I | 1 |
| Loiselle, SE | 1 |
| Rezende, F | 1 |
| Lodygensky, G | 1 |
| Hebert, TE | 1 |
| Ong, H | 1 |
| Chemtob, S | 1 |
| Droho, S | 1 |
| Cuda, CM | 1 |
| Perlman, H | 1 |
| Lavine, JA | 3 |
| Nourinia, R | 1 |
| Rezaei Kanavi, M | 1 |
| Kaharkaboudi, A | 1 |
| Taghavi, SI | 1 |
| Aldavood, SJ | 1 |
| Darjatmoko, SR | 1 |
| Wang, S | 2 |
| Gurel, Z | 1 |
| Safi, S | 1 |
| Ahmadieh, H | 1 |
| Daftarian, N | 1 |
| Sheibani, N | 2 |
| Sang, Y | 1 |
| Ip, MS | 1 |
4 other studies available for propranolol and Choroid Neovascularization
| Article | Year |
|---|---|
Propranolol Attenuates Proangiogenic Activity of Mononuclear Phagocytes: Implication in Choroidal Neovascularization.
Topics: Adrenergic beta-Antagonists; Angiogenesis Inhibitors; Animals; Blotting, Western; Caspase 3; Cell Li | 2019 |
Monocyte-Derived Macrophages Are Necessary for Beta-Adrenergic Receptor-Driven Choroidal Neovascularization Inhibition.
Topics: Adrenergic beta-Antagonists; Animals; Choroid; Choroidal Neovascularization; Disease Models, Animal; | 2019 |
Ocular Safety of Intravitreal Propranolol and Its Efficacy in Attenuation of Choroidal Neovascularization.
Topics: Adrenergic beta-Antagonists; Animals; Choroid; Choroidal Neovascularization; Disease Models, Animal; | 2015 |
Attenuation of choroidal neovascularization by β(2)-adrenoreceptor antagonism.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-2 Receptor | 2013 |